共 50 条
- [21] A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple MyelomaJOURNAL OF IMMUNOTHERAPY, 2022, 45 (02) : 78 - 88Xiong, MengshangLiu, RuoqiLei, XiaominFan, DongmeiLin, FangzhenHao, WeiYuan, XiangfeiYang, YuanyuanZhang, XiaolongYe, ZhouLu, YangZhang, YanjunWang, JianxiangXiong, Dongsheng
- [22] Anti-GPC3 TRAB, a first-in-class T cell-redirecting bispecific antibody targeting glypican-3 with potent in vitro and in vivo antitumor efficacy against solid tumorsCANCER RESEARCH, 2016, 76Kinoshita, YasukoIshiguro, TakahiroSano, YujiAzuma, YumikoTsunenari, ToshiakiOno, NatsukiKayukawa, YokoUeda, OtoyaWada, Naoko A.Hino, HiroshiJishage, KoichiShiraiwa, HirotakeKamata-Sakurai, MikaNezu, JunichiEndo, Mika
- [23] A novel T-cell engaging bispecific antibody platform: Efficient In vivo tumor clearance with minimal cytokine releaseJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5Trinklein, NathanBoudreau, AndrewBuelow, BenClarke, StarlynnDang, KevinDavison, LauraAldred, Shelley ForceHarris, KatherineIyer, SuhasiniJorgensen, BrettOgana, HeatherDuy PhamPratap, PayalRangaswamy, UdayaSchellenberger, UteUgamraj, HarshadVafa, Omidvan Schooten, Wim
- [24] A phase I dose escalation and cohort expansion study of T-cell redirecting bispecific antibody against Glypican 3 in patients with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Hashimoto, KenjiPerera, AyeshOgita, YoshitakaNakamura, MikikoIshiguro, TakahiroSano, YujiKinoshita, YasukoSakurai, Mika KamataFrings, WernerKomatsu, Shun-ichiroKaneko, AkihisaUeda, MasamichiKishishita, ShoheiGianella-Borradori, Athos
- [25] Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor VaccinesJOURNAL OF IMMUNOTHERAPY, 2016, 39 (04) : 171 - 180Liu, JingweiZhang, ShurongHu, YuefengYang, ZhaominLi, JingpoLiu, XuesongDeng, LijuanWang, YueZhang, XiaoyanJiang, TingLu, Xu
- [26] Terraflow, a New High Parameter Data Analysis Tool, Reveals Systemic T-Cell Exhaustion and Dysfunctional Cytokine Production in Classical Hodgkin LymphomaBLOOD, 2021, 138Freeman, DanLam, LindaLi, TriAlexandre, JasonRaphael, Bruce G.Kaminetzky, DavidRuan, JiaChattopadhyay, PratipDiefenbach, Catherine S.
- [27] A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacyTHERANOSTICS, 2022, 12 (18): : 7788 - 7803Liu, DongQi, XuexiuWei, XiaoyiZhao, LijunWang, XuechunLi, ShuhongWang, ZhidongShi, LicaiXu, JieanHong, MeiLiu, ZhongZhao, LiliWang, XiankunZhang, BoZhang, YuhanWang, FengCao, Yu J.
- [28] Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokineMOLECULAR THERAPY, 2024, 32 (09) : 3114 - 3127Basnet, SaruVan der Heijden, MirteQuixabeira, Dafne C. A.Jirovec, EliseGronberg-Vaha-Koskela, Susanna A. M.Clubb, James H. A.Kanerva, AnnaPakola, SanteriHaybout, LynaArias, VictorHemminki, OttoKudling, TatianaZafar, SadiaCervera-Carrascon, VictorSantos, Joao M.Hemminki, Akseli
- [29] Discovery of JNJ-88549968, a Novel, First-in-Class CALRmutxCD3 T-Cell Redirecting Antibody for the Treatment of Myeloproliferative NeoplasmsBLOOD, 2023, 142Kuchnio, AnnaSamakai, ElsieHug, EvaBalmana, MeritxellJanssen, LutAmorim, RicardoCornelissen, IvoMajoros, AndreaBroux, MichaelTaneja, IshaTorti, VinceAgic, AzraMoritsch, StefanBenedetti, FilippoRosebrock, FelixPackman, KathrynArts, JaninePatel, SonalLomas, Oliver ChristopherDeyoung, M. PhillipZagrijtschuk, OlehElsayed, YusriConstantinescu, StefanKralovics, RobertPhilippar, Ulrike
- [30] Characterization of JNJ-79635322, a Novel BCMAxGPRC5DxCD3 T-Cell Redirecting Trispecific Antibody, for the Treatment of Multiple MyelomaBLOOD, 2023, 142Pillarisetti, RamYang, DanlinYao, JianhongSmith, MelissaLuistro, LeopoldoVulfson, PeterJames, Testa, Jr.Packman, KathrynBrodeur, ScottAttar, Ricardo M.Elsayed, YusriPhilippar, Ulrike